5-MeO-DALT

5-MeO-DALT
	File:5-methoxy-DALT.svg
Identifiers
	IUPAC name N-allyl-N-[2-(5-methoxy; -1H-indol-3-yl)ethyl]; prop-2-en-1-amine;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C17H22N2O
Molar mass	270.375 g/mol
3D model (JSmol)	Interactive image;
	SMILES COc2ccc1ncc(CCN(CC=C)CC=C)c1c2;

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

5-MeO-DALT (N,N-diallyl-5-methoxytryptamine) is a psychedelic tryptamine believed to be first synthesized by Alexander Shulgin.

Chemistry

The full name of the chemical is N-allyl-N-[2-(5-methoxy
-1H-indol-3-yl)ethyl]prop-2-en-1-amine. It is very closely related to the compound 5-MeO-DPT and DALT.

Dosage

5-MeO-DALT is usually taken orally at dosages of 12-25mg.

Effects

5-MeO-DALT produces rapid, intense entheogenic effects, and it is very short-acting; effects are usually over within 2-4 hours. According to many users, the compound is said to be completely void of visual/hallucinogenic activity, unlike other closely related substances.

Dangers

There have been no reported deaths or hospitalizations from 5-MeO-DALT, but its safety profile is unknown.

Legality

5-MeO-DALT is unscheduled and uncontrolled in the United States, but possession and sales of 5-MeO-DALT could be prosecuted under the Federal Analog Act because of its structural similarities to other Schedule I substances.

External links

Template:Entactogens Template:Tryptamines

Template:WikiDoc Sources